Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA TRIAL) May 5, 2022 By Jesse Bufkin
A Phase 2 Open Label Single Arm Study Evaluating the Safety, Efficacy, and Pharmacokinetics of KX2-391 in Patients with Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior Chemotherapy May 5, 2022 By Jesse Bufkin
A Randomized Phase II Study of OGX-427 (a Second-Generation Antisense oligonucleotide to Heat Shock Protein-27) in Patients with Castration Resistant Prostate Cancer Who Have Not Previously Received Chemotherapy for Metastatic Disease May 5, 2022 By Jesse Bufkin
RANDOMIZED, PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CONVENTIONALCHEMORADIATION AND ADJUVANT TEMOZOLOMIDE PLUS CEDIRANIB VERSUSCONVENTIONAL CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE PLUS PLACEBO IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA May 5, 2022 By Jesse Bufkin
Clinical Development and Application of Novel Methods of Immunologic Monitoring for Assessing Cancer Immunotherapies May 5, 2022 By Jesse Bufkin
Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas May 5, 2022 By Jesse Bufkin
Protocol to Participate as a Donor of Peripheral Blood Mononuclear Cells to Provide Cells for Laboratory Research and Process Development Studies May 5, 2022 By Jesse Bufkin
Clinical Study of the Second Generation UW/Nucleus Vestibular Neurostimulator May 5, 2022 By Jesse Bufkin
